Metabolic and cellular research
Best Peptides for Weight Loss, Ranked by Evidence
Weight loss is the most searched peptide topic and also the one with the widest evidence gap between compounds. One entry on this list is an investigational drug with a large published trial. The rest are research compounds with animal or mechanistic data only. Ranked by how much human evidence actually exists, not by how popular a compound is online.
Editorial review: September 14, 2026. Ranked by evidence strength, not popularity.
Key takeaways
Ranked by what has actually been studied
- Strongest human evidence: Retatrutide
- Mechanistic rationale, preclinical stage: AOD-9604
- Exercise-linked signal, early stage: MOTS-c
- Target under active investigation: 5-Amino-1MQ
Retatrutide · Strongest human evidence
The only compound here with a published, placebo controlled trial in people. A 2023 phase 2 study in 338 adults with obesity reported weight loss up to 24.2% at the highest dose over 48 weeks against 2.1% for placebo. It is an investigational drug, not an approved medicine, and the trial used clinical supervision this guide cannot replace.
Read the Retatrutide research guide →AOD-9604 · Mechanistic rationale, preclinical stage
A fragment of human growth hormone studied for fat metabolism effects without growth-promoting activity. Evidence is preclinical; there is no equivalent large human weight loss trial to point to.
Read the AOD-9604 research guide →MOTS-c · Exercise-linked signal, early stage
A mitochondrial-derived peptide linked to muscle insulin sensitivity in animal and limited human observational work. Interesting mechanism, not a demonstrated weight loss intervention in controlled trials.
Read the MOTS-c research guide →5-Amino-1MQ · Target under active investigation
Works by inhibiting an enzyme (NNMT) tied to NAD+ depletion and fat cell metabolism. The target is legitimate research territory; the compound itself has preclinical, not clinical, backing.
Read the 5-Amino-1MQ research guide →Reign Peptide · Business disclosure
Research product listings
Jorge Abreu is involved in Reign Peptide. Links to Reign are a business connection, not an independent endorsement. Reign lists these products for laboratory research, not human consumption.
Use the listing to check the labeled identity, amount and available batch documentation. A purity result alone does not verify sterility, clinical suitability or equivalence to a medicine used in a trial.
Names and sizes are product labels, not dosing recommendations. Confirm current details with the seller.